Shares of homebuilding and housing-related companies are trading lower after worse-than-expected June new building permits data. Also, single-family housing starts fell 0.2% month-on-month, putting the annual starts rate 3.2% below its year-ago level.

DA Davidson Initiates Coverage On CRH with Buy Rating, Announces Price Target of $137

DA Davidson analyst Garik Shmois initiates coverage on CRH (NYSE:CRH) with a Buy rating and announces Price Target of $137.

Stephens & Co. Maintains Overweight on CRH, Lowers Price Target to $125

Stephens & Co. analyst Trey Grooms maintains CRH (NYSE:CRH) with a Overweight and lowers the price target from $135 to $125.

Truist Securities Maintains Buy on CRH, Lowers Price Target to $130

CRH Affirms FY2026 GAAP EPS Guidance of $5.60-$6.05 vs $5.97 Est

CRH (NYSE:CRH) affirms FY2026 GAAP EPS guidance from $5.60-$6.05 to $5.60-$6.05 vs $5.97 analyst estimate..

Greg Abel Just Made 3 Moves at Berkshire Hathaway That Bet on the Same Trend (And it's Not AI)

Berkshire Hathaway CEO Greg Abel is making significant bets on a housing market recovery through multiple moves: acquiring homebuilder Taylor Morrison for $8.5 billion, increasing investment in Lennar by 30%, and buying shares of D.R. Horton. These moves, combined with existing holdings in Clayton Homes and Berkshire Hathaway Home Services, suggest Abel believes pent-up demand will emerge once mortgage rates decline, despite the currently frozen housing market.

Mold Is Becoming a Costly New Headache for Homebuilders — D.R. Horton and Lennar Are Paying the Price

Mold lawsuits are raising legal costs for US home builders as homeowners allege health problems and construction defects.